Welcome to our dedicated page for Schrodinger SEC filings (Ticker: SDGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Schrödinger, Inc. (SDGR) SEC filings page on Stock Titan provides access to the company’s U.S. Securities and Exchange Commission disclosures, alongside AI-powered tools that help interpret key documents. As a Nasdaq-listed issuer, Schrödinger files current reports on Form 8-K, annual reports on Form 10-K and quarterly reports on Form 10-Q, among other documents, to provide transparency into its operations, governance and financial condition.
Recent Form 8-K filings illustrate the range of topics covered in SDGR’s regulatory reporting. The company has furnished press releases announcing quarterly financial results under Item 2.02, giving detail on software revenue, drug discovery revenue, software gross margin, operating expenses, cash position and non-GAAP measures. Other 8-K filings describe matters such as the submission of proposals to stockholders at the annual meeting, voting outcomes for director elections, advisory votes on executive compensation and ratification of the independent registered public accounting firm.
Schrödinger has also used Form 8-K to disclose executive compensation and separation arrangements under Item 5.02, including a separation and release of claims agreement with a former executive vice president and chief financial officer. These filings outline severance-related payments, equity vesting terms, COBRA-related benefits and other contractual provisions, providing insight into the company’s executive compensation framework.
On Stock Titan, users can review SDGR’s 10-K and 10-Q filings for detailed discussions of its software and drug discovery activities, risk factors, segment information and accounting policies. AI-powered summaries help explain lengthy filings by highlighting important sections, such as revenue breakdowns between software and drug discovery, non-GAAP reconciliations and disclosures related to collaborations and equity investments. The platform also surfaces Form 4 insider transaction reports, allowing users to track equity awards and share transactions by directors and officers.
With real-time updates from EDGAR and AI-generated overviews, the Schrödinger SEC filings page is intended to make it easier to navigate complex regulatory documents, compare periods and understand how SDGR’s computational platform, collaborations and therapeutics portfolio are reflected in its official disclosures.
Schrodinger, Inc. officer Robert Lorne Abel reported an open-market sale of 1,300 shares of common stock on March 4, 2026 at $12.81 per share. After this transaction, he directly owned 55,897 shares.
According to the disclosure, the sale was executed under a Rule 10b5-1 trading plan adopted on August 25, 2025 and was a broker-assisted sale to cover withholding tax due upon the vesting of restricted stock units. The filing notes that this did not represent a discretionary trade by the officer and that his holdings include 49,824 unvested RSUs.
Jenny Herman reported a proposed sale of 608 shares of common stock. The sale is identified as Restricted Stock Vesting and dated 03/05/2026. The filing also lists prior dispositions of 752 shares on 02/10/2026 and 775 shares on 03/05/2026.
Kenneth P. Lorton submitted a Form 144 reporting transactions in the issuer's common stock. The filing lists a proposed sale tied to restricted stock vesting on 03/04/2026 and discloses 925 shares sold on 02/10/2026 for $12,703.77.
SDGR Rule 144 notice: the filing lists 1,094 common shares designated "to be sold" following restricted stock vesting on 03/04/2026 and cites NASDAQ as the market. The broker of record is Fidelity Brokerage Services LLC.
The filing also records a separate sale by Yvonne K. Tran of 776 common shares on 02/10/2026.
Fidelity Brokerage Services LLC submitted a Form 144 notice reporting 775 common shares proposed for sale tied to restricted stock vesting. The filer also disclosed prior sales of 752 common shares on 02/10/2026 for $10,370.38.
SDGR reports a Form 144 notice for proposed sales of 3,661 shares of common stock tied to restricted stock vesting on 03/04/2026. The filing records 5,560 shares sold during the past three months and lists Fidelity Brokerage Services LLC as an agent on 03/05/2026.
SanDisk (SDGR) filing a Form 144 discloses proposed sales of common stock tied to a restricted stock vesting and a recent disposition by an associated person. The broker listed is Fidelity Brokerage Services LLC and the filing references NASDAQ.
The notice lists 1,366 shares from a restricted stock vesting reported on 03/04/2026 as securities to be sold by the issuer, and a separate reported sale of 2,206 shares by Karen O. Akinsanya-Akiwumi on 03/02/2026 with proceeds shown as $26,454.36. The Form date shown is 03/05/2026.
SDGR filed a Rule 144 notice to sell securities. The filing lists 3,125 shares of Common Stock to be sold as a stock bonus on 03/04/2026. It also records 1,230 shares sold on 02/09/2026. The document shows 64,500,510 shares outstanding as of 03/04/2026.
Schrodinger, Inc. director Richard Friesner exercised stock options that converted into 160,527 shares of common stock. The options, granted on May 11, 2016, were fully vested and were exercised at a price of $3.07 per share.
Following the transaction, Friesner directly owned 682,224 shares of Schrodinger common stock, which includes 5,997 unvested restricted stock units. He also had indirect ownership of 694,925 shares through the RF 2018 grantor retained annuity trust and 28,328 shares held by his spouse.